Please read and agree to the
terms and conditions
of this site.
I agree
Medical Technology
/tech
Clear filters and search
Format
photo
Tags
boston blog main
3
×
boston top stories
boulder/denver blog main
boulder/denver top stories
congress
3
×
detroit blog main
detroit top stories
life sciences
national
national blog main
national top stories
new york blog main
new york top stories
raleigh-durham blog main
raleigh-durham top stories
san diego blog main
san diego top stories
san francisco blog main
san francisco top stories
seattle blog main
seattle top stories
texas blog main
texas top stories
wisconsin blog main
wisconsin top stories
biotech
celgene
crispr
eli lilly
fda
gene editing
glaxosmithkline
indiana blog main
indiana top stories
sanofi
2019
activism
acute hepatic porphyria
advaxis
aimmune therapeutics
What
bio
roundup
3
×
crispr
advanced
alnylam’s
approval
bff
big
biopharma
bosley's
bosley’s
bridge
bucks
cas
ceo
conference
congress
congressional
crime
deals
departure
devoted
disease
drug
easl
editas
executives
exit
feud
form
gene
group
guiding
isn’t
katrine
kicked
known
later
liver
major
Language
Current search:
congress
×
roundup
×
" boston blog main "
×
@xconomy.com
5 years ago
Bio Roundup: EASL Does It, Alnylam’s BFF, Gene Therapy Deals & More
@xconomy.com
5 years ago
Bio Roundup: New CRISPR Feud, A NY Splash, Pharma vs. Congress & More
@xconomy.com
5 years ago
Bio Roundup: Bosley’s Editas Exit, Bridge Bucks, CRISPR Crime & More